Fund Holdings — Tri Locum Partners LP

Total Portfolio Value:
$288.37M
Total Bought:
$174.49M
Total Sold:
$93.84M
Net Transaction:
+$80.65M
Notable People:
Tri Locum Partners Gp Llc
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Teva Pharmaceutical Industries LimitedADS(TEVA)1,794,3352,216,188+421,853$18.73M$31.27M10.84%+$12.54M
Avadel Pharmaceuticals PlcADR839,9331,189,511+349,578$11.86M$20.09M6.97%+$8.23M
Silk Rd Med Inc01,083,605+1,083,605$0$19.85M6.88%+$19.85M
Natera, Inc.(NTRA)141,847190,114+48,267$8.89M$17.39M6.03%+$8.50M
Ascendis Pharma A/SADR(ASND)99,550112,670+13,120$12.54M$17.03M5.91%+$4.49M
Legend Biotech CorporationADS(LEGN)102,215283,773+181,558$6.15M$15.92M5.52%+$9.77M
Merck & Co., Inc.(MRK)0119,200+119,200$0$15.73M5.45%+$15.73M
Vertex Pharmaceuticals Incorporated(VRTX)035,598+35,598$0$14.88M5.16%+$14.88M
Madrigal Pharmaceuticals, Inc.(MDGL)25,52453,355+27,831$5.91M$14.25M4.94%+$8.34M
Baxter Intl Inc0317,566+317,566$0$13.57M4.71%+$13.57M
Merus N V0286,322+286,322$0$12.89M4.47%+$12.89M
Tandem Diabetes Care, Inc.(TNDM)0326,506+326,506$0$11.56M4.01%+$11.56M
argenx SEADR(ARGX)24,18227,981+3,799$9.20M$11.02M3.82%+$1.82M
Xenon Pharmaceuticals Inc.(XENE)225,564207,465-18,099$10.39M$8.93M3.10%-$1.46M
Regeneron Pharmaceuticals, Inc.(REGN)16,0128,567-7,445$14.06M$8.25M2.86%-$5.82M
Axsome Therapeutics, Inc.(AXSM)130,738102,711-28,027$10.41M$8.20M2.84%-$2.21M
Praxis Precision Medicines, Inc.(PRAX)248,761106,494-142,267$5.54M$6.50M2.25%+$955.9K
Endeavour Silver Corp.(EXK)090,000+90,000$0$6.22M2.16%+$6.22M
Lyra Therapeutics Inc0978,793+978,793$0$6.09M2.11%+$6.09M
Astria Therapeutics Inc542,945369,549-173,396$4.17M$5.20M1.80%+$1.03M
Inspire Medical Systems, Inc.(INSP)023,566+23,566$0$5.06M1.76%+$5.06M
Alpine Immune Sciences Inc0120,687+120,687$0$4.78M1.66%+$4.78M
Arcturus Therapeutics Holdings Inc.(ARCT)110,470138,927+28,457$3.48M$4.69M1.63%+$1.21M
Arcutis Biotherapeutics, Inc.(ARQT)0449,694+449,694$0$4.46M1.55%+$4.46M
Mind Medicine Mindmed Inc0379,596+379,596$0$3.57M1.24%+$3.57M
Perspective Therapeutics, Inc.(CATX)0780,303+780,303$0$928.6K0.32%+$928.6K
Femasys Inc36,15030,606-5,544$35.2K$47.4K0.02%+$12.2K
AbbVie Inc.(ABBV)167,8070-167,807$26.01M$0—-$26.01M
AstraZeneca PLCADR(AZN)58,7870-58,787$3.96M$0—-$3.96M
Biogen Inc.(BIIB)45,8140-45,814$11.86M$0—-$11.86M
Catalent Inc261,7970-261,797$11.76M$0—-$11.76M
GE HealthCare Technologies Inc.(GEHC)171,6760-171,676$13.27M$0—-$13.27M
Immatics N.V.SHS(IMTX)275,4820-275,482$2.90M$0—-$2.90M
MoonLake ImmunotherapeuticsCL A(MLTX)47,6040-47,604$2.87M$0—-$2.87M
Scholar Rock Holding Corporation(SRRK)207,1470-207,147$3.89M$0—-$3.89M
Verona Pharma PlcADS293,1120-293,112$5.83M$0—-$5.83M
Page 1 of 1
Tri Locum Partners LP — 13F Holdings — Q1 2024 | TickerTrail